These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 36872898)

  • 1. The Detection of Hypercoagulability in Patients with Acute Cerebral Infarction Using a Clot Waveform Analysis.
    Kamon T; Horie S; Inaba T; Ito N; Shiraki K; Ichikawa Y; Ezaki M; Shimpo H; Shimaoka M; Nishigaki A; Shindo A; Wada H
    Clin Appl Thromb Hemost; 2023; 29():10760296231161591. PubMed ID: 36872898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Clot Waveform Analysis Showing a Hypercoagulable State in Patients with Malignant Neoplasms.
    Kobayashi M; Wada H; Fukui S; Mizutani H; Ichikawa Y; Shiraki K; Moritani I; Inoue H; Shimaoka M; Shimpo H
    J Clin Med; 2021 Nov; 10(22):. PubMed ID: 34830633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of a Prethrombotic State in Patients with Hepatocellular Carcinoma, Using a Clot Waveform Analysis.
    Fukui S; Wada H; Ikeda K; Kobayashi M; Shimada Y; Nakazawa Y; Mizutani H; Ichikawa Y; Nishiura Y; Moritani I; Yamanaka Y; Inoue H; Shimaoka M; Shimpo H; Shiraki K
    Clin Appl Thromb Hemost; 2024; 30():10760296241246002. PubMed ID: 38591954
    [No Abstract]   [Full Text] [Related]  

  • 4. Clot Waveform Analysis Demonstrates Low Blood Coagulation Ability in Patients with Idiopathic Thrombocytopenic Purpura.
    Wada H; Ichikawa Y; Ezaki M; Shiraki K; Moritani I; Yamashita Y; Matsumoto T; Masuya M; Tawara I; Shimpo H; Shimaoka M
    J Clin Med; 2021 Dec; 10(24):. PubMed ID: 34945283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Evaluation of Hemostatic Abnormalities Using a CWA-Small Amount Tissue Factor Induced FIX Activation Assay in Major Orthopedic Surgery Patients.
    Hasegawa M; Tone S; Wada H; Naito Y; Matsumoto T; Yamashita Y; Shimaoka M; Sudo A
    Clin Appl Thromb Hemost; 2021; 27():10760296211012094. PubMed ID: 34027710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clot Waveform Analysis for Hemostatic Abnormalities.
    Wada H; Shiraki K; Matsumoto T; Shimpo H; Shimaoka M
    Ann Lab Med; 2023 Nov; 43(6):531-538. PubMed ID: 37387486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Evaluation of Clot Waveform Analyses for Assessing Hypercoagulability in Patients Treated with Factor VIII Concentrate.
    Matsumoto T; Wada H; Shiraki K; Suzuki K; Yamashita Y; Tawara I; Shimpo H; Shimaoka M
    J Clin Med; 2023 Sep; 12(19):. PubMed ID: 37834964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluating Factor VIII Concentrates Using Clot Waveform Analysis.
    Wada H; Shiraki K; Matsumoto T; Shimpo H; Sakano Y; Nishii H; Tamaki S; Suzuki K; Tawara I; Yamashita Y; Shimaoka M
    J Clin Med; 2024 Jun; 13(13):. PubMed ID: 38999423
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of platelet and phospholipids on clot formation activated by a small amount of tissue factor.
    Wada H; Shiraki K; Matsumoto T; Ohishi K; Shimpo H; Shimaoka M
    Thromb Res; 2020 Sep; 193():146-153. PubMed ID: 32559572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Evaluation of APTT Reagents in Reference Plasma, Recombinant FVIII Products; Kovaltry® and Jivi® Using CWA, Including sTF/7FIX Assay.
    Wada H; Shiraki K; Matsumoto T; Ohishi K; Shimpo H; Sakano Y; Nishii H; Shimaoka M
    Clin Appl Thromb Hemost; 2021; 27():1076029620976913. PubMed ID: 33606948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated activated partial thromboplastin time-based clot waveform analysis markers have strong positive association with acute venous thromboembolism.
    Tan CW; Cheen MHH; Wong WH; Wu IQ; Chua BLW; Ahamedulla SH; Lee LH; Ng HJ
    Biochem Med (Zagreb); 2019 Jun; 29(2):020710. PubMed ID: 31223264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Performance and Interpretation of Clot Waveform Analysis.
    Ruberto MF; Marongiu F; Barcellona D
    Methods Mol Biol; 2023; 2663():163-173. PubMed ID: 37204709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coagulation Status Using Clot Wave Analysis in Patients With Prolonged Immobilization.
    Iberahim S; Muhamat Yusoff R; Mohd Noor NH; Hassan R; Ramli NN; Bahar R; Zulkafli Z; Wan Ab Rahman WS; Ab Ghani AS
    Cureus; 2024 Jan; 16(1):e51483. PubMed ID: 38304638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of coagulation status using clot waveform analysis in general ward patients with COVID-19.
    Ichikawa J; Okazaki R; Fukuda T; Ono T; Ishikawa M; Komori M
    J Thromb Thrombolysis; 2022 Jan; 53(1):118-122. PubMed ID: 34263423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Update on the Clot Waveform Analysis.
    Wada H; Matsumoto T; Ohishi K; Shiraki K; Shimaoka M
    Clin Appl Thromb Hemost; 2020; 26():1076029620912027. PubMed ID: 32862666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic analysis of lupus anticoagulant using clot waveform analysis in activated partial thromboplastin time prolonged cases: A retrospective analysis.
    Kanouchi K; Narimatsu H; Shirata T; Morikane K
    Health Sci Rep; 2021 Jun; 4(2):e258. PubMed ID: 33738342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clot waveform analysis in acute promyelocytic leukemia.
    Terras M; El Borgi W; Betbout W; Jaied R; Lakhal FB; Salem SF; Ghali O; Gouider E
    Blood Coagul Fibrinolysis; 2024 Jan; 35(1):27-31. PubMed ID: 37994627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening of the protein C pathway abnormality-related thrombophilia by using thrombomodulin-mediated tissue factor-triggered clot waveform analysis.
    Hashimoto N; Ogiwara K; Shimonishi N; Nakagawa T; Nakajima Y; Furukawa S; Takeyama M; Nogami K
    Eur J Haematol; 2022 Jul; 109(1):100-108. PubMed ID: 35430749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clot Waveform Analysis: From Hypercoagulability to Hypocoagulability - A Review.
    Marongiu F; Ruberto MF; Marongiu S; Barcellona D
    Arch Pathol Lab Med; 2024 Feb; ():. PubMed ID: 38375736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences in the Composition of Activated Partial Thromboplastin Time (APTT) Reagents Affect Clot Waveform Analysis.
    Kato K; Hatayama Y; Shimohiro H; Ichikawa H; Fukuda T
    Yonago Acta Med; 2022 Aug; 65(3):226-230. PubMed ID: 36061578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.